Filed 2.8y ago· Aug 13, 2023
34 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 101–155 of 155
Filed 2.8y ago· Aug 10, 2023
828 days to disclose · 783 past 45-day window
Rick W. Allen
RHouseGeorgia-12
↑bought
Johnson & Johnson
JNJ
$15K-$50K
−36.2% vs S&P 500
Trade dateMay 4, 2021
⚑ Pharmaceutical
Filed 2.9y ago· Jul 12, 2023
26 days to disclose
Kevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−24.8% vs S&P 500
Trade dateJun 16, 2023
⚑ Pharmaceutical
Filed 2.9y ago· Jul 10, 2023
27 days to disclose
Lloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−22.0% vs S&P 500
Trade dateJun 13, 2023
⚑ Pharmaceutical
Filed 3.2y ago· Apr 10, 2023
13 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−30.6% vs S&P 500
Trade dateMar 28, 2023
⚑ Pharmaceutical
Filed 3.2y ago· Apr 10, 2023
28 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+31.8% vs S&P 500
Trade dateMar 13, 2023
⚑ Pharmaceutical
Filed 3.2y ago· Mar 20, 2023
21 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+32.7% vs S&P 500
Trade dateFeb 27, 2023
Filed 3.2y ago· Mar 13, 2023
24 days to disclose
Lois Frankel
DHouseFlorida-22
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+33.9% vs S&P 500
Trade dateFeb 17, 2023
Filed 3.2y ago· Mar 11, 2023
15 days to disclose
Thomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+15.6% vs S&P 500
Trade dateFeb 24, 2023
⚑ Pharmaceutical
Filed 3.3y ago· Feb 17, 2023
37 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+9.8% vs S&P 500
Trade dateJan 11, 2023
Filed 3.3y ago· Feb 14, 2023
14 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+36.4% vs S&P 500
Trade dateJan 31, 2023
⚑ Pharmaceutical
Filed 3.3y ago· Feb 11, 2023
32 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+10.4% vs S&P 500
Trade dateJan 10, 2023
⚑ Pharmaceutical
Filed 3.4y ago· Jan 5, 2023
23 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−50.7% vs S&P 500
Trade dateDec 13, 2022
⚑ Pharmaceutical
Filed 3.5y ago· Dec 19, 2022
1083 days to disclose · 1038 past 45-day window
Thomas R. Suozzi
DHouseNew York-03
↑bought
Johnson & Johnson
JNJ
$15K-$50K
Trade dateJan 1, 2020
2000084479 Johnson & Johnson
⚑ Pharmaceutical
Filed 3.5y ago· Dec 12, 2022
34 days to disclose
Christopher L. Jacobs
RHouseNew York-27
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+21.3% vs S&P 500
Trade dateNov 8, 2022
Filed 3.6y ago· Nov 13, 2022
27 days to disclose
Shelley Moore Capito
RSenateWest Virginia
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+18.0% vs S&P 500
Trade dateOct 17, 2022
⚑ Pharmaceutical
Filed 3.6y ago· Nov 13, 2022
27 days to discloseShelley Moore Capito
RSenateWest Virginia
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+18.0% vs S&P 500
Trade dateOct 17, 2022
⚑ Pharmaceutical
Filed 3.6y ago· Nov 10, 2022
29 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+20.3% vs S&P 500
Trade dateOct 12, 2022
Filed 3.6y ago· Nov 1, 2022
50 days to disclose · 5 past 45-day windowLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+26.6% vs S&P 500
Trade dateSep 12, 2022
⚑ Pharmaceutical
Filed 3.6y ago· Oct 11, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+26.6% vs S&P 500
Trade dateSep 12, 2022
Filed 3.7y ago· Sep 14, 2022
42 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+12.4% vs S&P 500
Trade dateAug 3, 2022
Filed 3.8y ago· Sep 2, 2022
296 days to disclose · 251 past 45-day window
Carol D. Miller
RHouseWest Virginia-01
↓sold
Johnson & Johnson
JNJ
$15K-$30K
+15.5% vs S&P 500
Trade dateNov 10, 2021
⚑ Pharmaceutical
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+15.7% vs S&P 500
Trade dateJul 15, 2022
Filed 3.9y ago· Jul 11, 2022
31 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−51.3% vs S&P 500
Trade dateJun 10, 2022
⚑ Pharmaceutical
Filed 3.9y ago· Jul 8, 2022
10 days to disclose
John R. Curtis
RSenateUtah
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+59.0% vs S&P 500
Trade dateJun 28, 2022
⚑ Pharmaceutical
Filed 4.0y ago· Jun 9, 2022
29 days to discloseLois Frankel
DHouseFlorida-22
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+13.5% vs S&P 500
Trade dateMay 11, 2022
Filed 4.0y ago· Jun 9, 2022
45 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+10.4% vs S&P 500
Trade dateApr 25, 2022
Filed 4.0y ago· Jun 3, 2022
22 days to disclose
Cindy Axne
—HouseIowa-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+16.7% vs S&P 500
Trade dateMay 12, 2022
Filed 4.0y ago· Jun 3, 2022
30 days to discloseCindy Axne
—HouseIowa-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+11.9% vs S&P 500
Trade dateMay 4, 2022
Filed 4.0y ago· Jun 3, 2022
30 days to discloseCindy Axne
—HouseIowa-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+11.9% vs S&P 500
Trade dateMay 4, 2022
Filed 4.1y ago· Apr 19, 2022
34 days to disclose
John H. Rutherford
RHouseFlorida-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+10.8% vs S&P 500
Trade dateMar 16, 2022
Filed 4.2y ago· Mar 23, 2022
14 days to discloseJohn R. Curtis
RSenateUtah
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+14.3% vs S&P 500
Trade dateMar 9, 2022
⚑ Pharmaceutical
Filed 4.3y ago· Feb 3, 2022
16 days to disclose
Thomas R Carper
DSenateDelaware
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−20.3% vs S&P 500
Trade dateJan 18, 2022
Filed 4.6y ago· Oct 18, 2021
35 days to disclose
Robert J. Wittman
RHouseVirginia-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+12.2% vs S&P 500
Trade dateSep 13, 2021
Filed 4.6y ago· Oct 18, 2021
47 days to disclose · 2 past 45-day windowRobert J. Wittman
RHouseVirginia-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+9.8% vs S&P 500
Trade dateSep 1, 2021
Filed 4.6y ago· Oct 15, 2021
15 days to disclose
Tommy Tuberville
RSenateAlabama
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+28.0% vs S&P 500
Trade dateSep 30, 2021
⚑ Pharmaceutical
Filed 4.7y ago· Oct 8, 2021
535 days to disclose · 490 past 45-day windowCindy Axne
—HouseIowa-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateApr 21, 2020
Filed 4.7y ago· Oct 8, 2021
603 days to disclose · 558 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateFeb 13, 2020
Filed 4.7y ago· Oct 8, 2021
603 days to disclose · 558 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateFeb 13, 2020
Filed 4.7y ago· Oct 8, 2021
647 days to disclose · 602 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateDec 31, 2019
Filed 4.7y ago· Oct 8, 2021
813 days to disclose · 768 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateJul 18, 2019
Filed 4.7y ago· Oct 8, 2021
940 days to disclose · 895 past 45-day windowCindy Axne
—HouseIowa-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateMar 13, 2019
Filed 4.7y ago· Oct 7, 2021
30 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+30.4% vs S&P 500
Trade dateSep 7, 2021
⚑ Pharmaceutical
Filed 4.7y ago· Sep 23, 2021
1387 days to disclose · 1342 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateDec 6, 2017
⚑ Pharmaceutical
Filed 4.9y ago· Jul 23, 2021
116 days to disclose · 71 past 45-day windowTommy Tuberville
RSenateAlabama
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateMar 29, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 17, 2021
44 days to disclose
Blake D. Moore
RHouseUtah-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+22.0% vs S&P 500
Trade dateJun 3, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 17, 2021
113 days to disclose · 68 past 45-day windowBlake D. Moore
RHouseUtah-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateMar 26, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 17, 2021
135 days to disclose · 90 past 45-day windowBlake D. Moore
RHouseUtah-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateMar 4, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 17, 2021
143 days to disclose · 98 past 45-day windowBlake D. Moore
RHouseUtah-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
Trade dateFeb 24, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 12, 2021
30 days to discloseRick W. Allen
RHouseGeorgia-12
↓sold
Johnson & Johnson
JNJ
$15K-$30K
+40.2% vs S&P 500
Trade dateMay 13, 2021
⚑ Pharmaceutical
Filed 5.1y ago· May 9, 2021
16 days to disclose
Marie Newman
—HouseIllinois-03
↓sold
Johnson & Johnson
JNJ
$15K-$50K
Trade dateApr 23, 2021
Filed 5.1y ago· May 9, 2021
38 days to discloseMarie Newman
—HouseIllinois-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateApr 1, 2021
Filed 5.1y ago· May 6, 2021
6 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$15K-$30K
−31.3% vs S&P 500
Trade dateApr 30, 2021
Filed 5.1y ago· May 2, 2021
381 days to disclose · 336 past 45-day windowDJ
David A Perdue , Jr
—Senate
↓sold
Johnson & Johnson
JNJ
$1K-$15K
Trade dateApr 16, 2020
Filed 5.1y ago· May 2, 2021
383 days to disclose · 338 past 45-day windowDJ
David A Perdue , Jr
—Senate
↓sold
Johnson & Johnson
JNJ
$50K-$100K
Trade dateApr 14, 2020
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Johnson & Johnson JNJ | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | May 4, 2021 828 days to disclose · 783 past 45-day window | Good buy·+$11.6K+35.6% −36.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 12, 2023 2.9y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 16, 2023 26 days to disclose | Good buy·+$3.1K+38.5% −24.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 10, 2023 2.9y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 13, 2023 27 days to disclose | Good buy·+$3.3K+41.5% −22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2023 3.2y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 28, 2023 13 days to disclose | Good buy·+$4K+49.8% −30.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2023 3.2y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 13, 2023 28 days to disclose | Good buy·+$4K+50.3% +31.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2023 3.2y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Johnson & Johnson JNJ | Feb 27, 2023 21 days to disclose | Good buy·+$3.9K+48.6% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 13, 2023 3.2y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | Feb 17, 2023 24 days to disclose | Good buy·+$3.7K+46.4% +33.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 11, 2023 3.2y ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Feb 24, 2023 15 days to disclose | Flat·+0.0% +15.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 17, 2023 3.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Jan 11, 2023 37 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 31, 2023 14 days to disclose | Missed gain·−$3.1K-39.2% +36.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2023 3.3y ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jan 10, 2023 32 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 5, 2023 3.4y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 13, 2022 23 days to disclose | Good buy·+$2.2K+26.9% −50.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↑bought | Johnson & Johnson JNJ 2000084479 Johnson & Johnson ⚑ Pharmaceutical · Ways and Means | Jan 1, 2020 1083 days to disclose · 1038 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Dec 12, 2022 3.5y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Johnson & Johnson JNJ | Nov 8, 2022 34 days to disclose | Good buy·+$2.6K+33.1% +21.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 13, 2022 3.6y ago | Shelley Moore Capito RSenateWest Virginia | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 17, 2022 27 days to disclose | Flat·+0.0% +18.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 13, 2022 3.6y ago | Shelley Moore Capito RSenateWest Virginia | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 17, 2022 27 days to disclose | Flat·+0.0% +18.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Oct 12, 2022 29 days to disclose | Good buy·+$3.4K+42.2% +20.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2022 3.6y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 12, 2022 50 days to disclose · 5 past 45-day window | Good buy·+$3.2K+39.6% +26.6% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Sep 12, 2022 29 days to disclose | Good buy·+$3.2K+39.6% +26.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Johnson & Johnson JNJ | Aug 3, 2022 42 days to disclose | Flat·+0.0% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Nov 10, 2021 296 days to disclose · 251 past 45-day window | Missed gain·−$8.7K-38.5% +15.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 15, 2022 26 days to disclose | Good buy·+$2.4K+29.8% +15.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 11, 2022 3.9y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 10, 2022 31 days to disclose | Good buy·+$2.5K+31.8% −51.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 8, 2022 3.9y ago | John R. Curtis RSenateUtah | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jun 28, 2022 10 days to disclose | Missed gain·−$2.3K-28.6% +59.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2022 4.0y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | May 11, 2022 29 days to disclose | Good buy·+$2.5K+31.3% +13.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2022 4.0y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Johnson & Johnson JNJ | Apr 25, 2022 45 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 3, 2022 4.0y ago | Cindy Axne —HouseIowa-03 | ↓sold | Johnson & Johnson JNJ | May 12, 2022 22 days to disclose | Flat·+0.0% +16.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 3, 2022 4.0y ago | Cindy Axne —HouseIowa-03 | ↓sold | Johnson & Johnson JNJ | May 4, 2022 30 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 3, 2022 4.0y ago | Cindy Axne —HouseIowa-03 | ↓sold | Johnson & Johnson JNJ | May 4, 2022 30 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 19, 2022 4.1y ago | John H. Rutherford RHouseFlorida-05 | ↓sold | Johnson & Johnson JNJ | Mar 16, 2022 34 days to disclose | Flat·+0.0% +10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 23, 2022 4.2y ago | John R. Curtis RSenateUtah | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Mar 9, 2022 14 days to disclose | Flat·+0.0% +14.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 3, 2022 4.3y ago | Thomas R Carper DSenateDelaware | ↑bought | Johnson & Johnson JNJ | Jan 18, 2022 16 days to disclose | Good buy·+$2.9K+36.1% −20.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 18, 2021 4.6y ago | Robert J. Wittman RHouseVirginia-01 | ↓sold | Johnson & Johnson JNJ | Sep 13, 2021 35 days to disclose | Flat·+0.0% +12.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 18, 2021 4.6y ago | Robert J. Wittman RHouseVirginia-01 | ↓sold | Johnson & Johnson JNJ | Sep 1, 2021 47 days to disclose · 2 past 45-day window | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 15, 2021 4.6y ago | Tommy Tuberville RSenateAlabama | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Sep 30, 2021 15 days to disclose | Good buy·+$3.6K+44.7% +28.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↓sold | Johnson & Johnson JNJ | Apr 21, 2020 535 days to disclose · 490 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Feb 13, 2020 603 days to disclose · 558 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Feb 13, 2020 603 days to disclose · 558 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Dec 31, 2019 647 days to disclose · 602 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Jul 18, 2019 813 days to disclose · 768 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 8, 2021 4.7y ago | Cindy Axne —HouseIowa-03 | ↑bought | Johnson & Johnson JNJ | Mar 13, 2019 940 days to disclose · 895 past 45-day window | price pending | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 7, 2021 30 days to disclose | Good buy·+$3.2K+39.5% +30.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 6, 2017 1387 days to disclose · 1342 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 23, 2021 4.9y ago | Tommy Tuberville RSenateAlabama | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 29, 2021 116 days to disclose · 71 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | Blake D. Moore RHouseUtah-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 3, 2021 44 days to disclose | Flat·+0.0% +22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | Blake D. Moore RHouseUtah-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 26, 2021 113 days to disclose · 68 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | Blake D. Moore RHouseUtah-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 4, 2021 135 days to disclose · 90 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | Blake D. Moore RHouseUtah-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Feb 24, 2021 143 days to disclose · 98 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jun 12, 2021 5.0y ago | Rick W. Allen RHouseGeorgia-12 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | May 13, 2021 30 days to disclose | Missed gain·−$7.6K-33.9% +40.2% vs S&P 500 | $15K-$30K midpoint $22.5K |
May 9, 2021 5.1y ago | Marie Newman —HouseIllinois-03 | ↓sold | Johnson & Johnson JNJ | Apr 23, 2021 16 days to disclose | price pending | $15K-$50K midpoint $32.5K |
May 9, 2021 5.1y ago | Marie Newman —HouseIllinois-03 | ↓sold | Johnson & Johnson JNJ | Apr 1, 2021 38 days to disclose | price pending | $1K-$15K midpoint $8K |
May 6, 2021 5.1y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Apr 30, 2021 6 days to disclose | Good buy·+$9K+39.8% −31.3% vs S&P 500 | $15K-$30K midpoint $22.5K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | Johnson & Johnson JNJ | Apr 16, 2020 381 days to disclose · 336 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | Johnson & Johnson JNJ | Apr 14, 2020 383 days to disclose · 338 past 45-day window | price pending | $50K-$100K midpoint $75K |